Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in relapsed or refractory multiple myeloma (Phase II, open-label)
2005-006024-11Phase 2Completed
- Sponsor
- University of Bonn
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sorafenib in multiple myeloma (MM), sponsored by University of Bonn. Primary endpoint: Progression-free survival. Started Jul 2006; status: completed.
02
Drugs
sorafenib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2005-006024-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006024-11.